Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

959 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group.
Kollmannsberger C, Rick O, Derigs HG, Schleucher N, Schöffski P, Beyer J, Schoch R, Sayer HG, Gerl A, Kuczyk M, Spott C, Kanz L, Bokemeyer C. Kollmannsberger C, et al. Among authors: bokemeyer c. J Clin Oncol. 2002 Apr 15;20(8):2031-7. doi: 10.1200/JCO.2002.08.050. J Clin Oncol. 2002. PMID: 11956262 Clinical Trial.
[Therapy of elderly patients with colorectal carcinoma].
Honecker F, Kolb G, Bokemeyer C. Honecker F, et al. Among authors: bokemeyer c. Wien Med Wochenschr. 2002;152(7-8):170-6. doi: 10.1046/j.1563-258x.2002.02026.x. Wien Med Wochenschr. 2002. PMID: 12017742 Review. German.
Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer.
Honecker F, Kollmannsberger C, Quietzsch D, Haag C, Schroeder M, Spott C, Hartmann JT, Baronius W, Hempel V, Kanz L, Bokemeyer C. Honecker F, et al. Among authors: bokemeyer c. Anticancer Drugs. 2002 Jun;13(5):497-503. doi: 10.1097/00001813-200206000-00008. Anticancer Drugs. 2002. PMID: 12045461 Clinical Trial.
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.
Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H, Honecker F, Bokemeyer C, Perlman EJ, Schneider DT, Kononen J, Sauter G, Oosterhuis JW. Looijenga LH, et al. Among authors: bokemeyer c. Cancer Res. 2003 May 1;63(9):2244-50. Cancer Res. 2003. PMID: 12727846
959 results